- Home
- Equities - Stocks - Shares
- Company Press Releases
- Schibsted ASA (SCHA/SCHB) - Corrective Note To Schibsted ASA's Annual Financial Reports For 2022 and 2023
Schibsted ASA (SCHA/SCHB) - Corrective note to Schibsted ASA's annual financial reports for 2022 and 2023
18 Dec 2024 20:42 CET
Issuer
Schibsted ASA
18.12.2024 20:42:28 CET | Schibsted | Annual financial and audit reports
Reference is made to the announcement from Financial Supervisory Authority of
Norway (the FSA) regarding their review of certain topics related to the 2022
and 2023 annual financial statements of Schibsted ASA with conclusions published
27 November 2024. The FSA concluded that it had found errors in the accounting
under the equity method in relation to the investment in the associate Adevinta
ASA concerning two matters:
* As Adevinta consistently issued its interim financial statements later than
Schibsted, Schibsted recognised its share of the associate's profit or loss
with a three-month delay. In its Q4 2022 interim report and its 2022 annual
financial statements, Schibsted thereby included share of profit (loss) from
Adevinta up and until Q3 2022. As Adevinta issued its Q4 2022 interim report
in the period between Schibsted issuing its Q4 2022 interim report and its
2022 annual financial statements, Schibsted did thereby not in its 2022
annual financial statements use the most recent available financial
statements for the associate (IAS 28.33) or adjusted for any effects of
significant transactions or events that occurred in the associate's available
fourth quarter report for 2022 (ref. IAS 28.34).
* In its 2023 annual financial statements, Schibsted recognised a reversal of
previously recognised impairment losses implying that the investment
effectively was measured at its fair value based on the quoted share price.
IAS 28.42 requires that any reversal of impairment loss shall be recognised
in accordance with IAS 36 to the extent that the recoverable amount
subsequently increases. The reversal of impairment loss recognised by
Schibsted exceeded the increase in the recoverable amount.
The FSA ordered Schibsted ASA to correct the errors by publicly disclosing a
corrective note by notifying the Oslo Stock Exchange.
The corrective note is an attachment to the previously issued annual financial
reports for 2022 and 2023 and includes an account of the nature of the errors
for the financial reports.
Schibsted has reassessed the figures in the financial statements using the
understanding of IFRS following from the order as follows:
1. Schibsted recognised in its 2023 annual financial statements its share of
impairment losses as reported by Adevinta in its Q4 2022 interim report.
Those impairment losses amounted to EUR 1,722 million (EUR 1,662 million net
of related taxes). Schibsted's share of those losses is now adjusted to be
recognised in 2022 as an adjustment for a significant event. The adjustments
to share of losses of Adevinta recognised, reduces the impairment losses
related to the investment to be recognised or reversed.
2. Similarly, Schibsted recognised in its Q1 2024 interim report its share of
impairment losses as reported by Adevinta in its Q4 2023 interim report.
Those impairment losses amounted to EUR 147 million (EUR 108 million net of
related taxes). Schibsted's share of those losses is adjusted to be
recognised in 2023 as an adjustment for a significant transaction or event.
3. The recoverable amount (fair value based on current share price) increased
by EUR 1,297 million from EUR 2,151 million (NOK 22,619 million) to EUR
3,448 million (NOK 38,756 million) during 2023. Reversal of impairment
losses recognised in 2023 is adjusted to reflect the limitation set by the
increase in recoverable amount of EUR 1,297 million (NOK 14,555 million)
Adevinta has EUR as its functional currency. Share of profit (loss) and other
changes in the net assets of Adevinta are determined in EUR and translated to
NOK at exchange rates applicable for each of those movements. The adjustments
thereby also affect foreign exchange differences in other comprehensive income
which are adjusted with NOK -57 million in 2022 and NOK 511 million in 2023.
The effect of the corrections on the consolidated financial statements for 2022
and 2023 are disclosed in the attached corrective note.
Oslo, 18 December 2024
SCHIBSTED ASA
DISCLOSURE REGULATION
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Malin Ebenfelt, Investor Relations Manager, +47 916 86 710, ir@schibsted.com
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847482/18364507/5436/Download%20announce
ment%20as%20PDF.pdf
Schibsted ASA corrective note to annual report 2022 and 2023.pdf -
https://kommunikasjon.ntb.no/ir-files/17847482/18364507/5433/Schibsted%20ASA%20c
orrective%20note%20to%20annual%20report%202022%20and%202023.pdf
Schibsted Annual Report 2022.pdf -
https://kommunikasjon.ntb.no/ir-files/17847482/18364507/5434/Schibsted%20Annual%
20Report%202022.pdf
Schibsted Annual Report 2023.pdf -
https://kommunikasjon.ntb.no/ir-files/17847482/18364507/5435/Schibsted%20Annual%
20Report%202023.pdf
More information:
Access the news on Oslo Bors NewsWeb site
635133_Download announcement as PDF.pdf
635133_Schibsted Annual Report 2022.pdf
635133_Schibsted Annual Report 2023.pdf
635133_Schibsted ASA corrective note to annual report 2022 and 2023.pdf
Source
Schibsted ASA
Provider
Oslo Børs Newspoint
Company Name
SCHIBSTED SER. A, SCHIBSTED SER. B, Schibsted ASA 23/28 FRN, Schibsted ASA 23/30 4,85%
ISIN
NO0003028904, NO0010736879, NO0012911306, NO0012911231
Symbol
SCHA, SCHB
Market
Oslo Børs